{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:22:24Z","timestamp":1790626944418,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","award":["KSRG-2023-154"],"award-info":[{"award-number":["KSRG-2023-154"]}],"id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijbiomac.2024.130544","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T01:11:18Z","timestamp":1709169078000},"page":"130544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P1","title":["A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"264","author":[{"given":"Abdelbaset Mohamed","family":"Elasbali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed Abu","family":"Al-Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan H.","family":"Alhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0005","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/biomedicines11030830","article-title":"A brief review of Duchenne muscular dystrophy treatment options, with an emphasis on two novel strategies","volume":"11","author":"Heydemann","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccm.2018.01.004","article-title":"Muscular dystrophies","volume":"39","author":"Carter","year":"2018","journal-title":"Clin. Chest Med."},{"issue":"10213","key":"10.1016\/j.ijbiomac.2024.130544_bb0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.130544_bb0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","article-title":"Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne\u2019s or Becker\u2019s muscular dystrophy","volume":"318","author":"Hoffman","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0025","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng0493-283","article-title":"The structural and functional diversity of dystrophin","volume":"3","author":"Ahn","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0035","series-title":"Duchenne Muscular Dystrophy","author":"Venugopal","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0040","first-page":"8A","article-title":"Maintenance of muscle cell membrane integrity and the pathogenesis of muscular dystrophy","author":"Campbell","year":"2008","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1566523223666221118160932","article-title":"Duchenne muscular dystrophy gene therapy","volume":"24","author":"Saad","year":"2024","journal-title":"Curr. Gene Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/BST20190282","article-title":"From diagnosis to therapy in Duchenne muscular dystrophy","volume":"48","author":"Babbs","year":"2020","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmg.2.1.38","article-title":"Muscular dystrophy (Duchenne) in a girl with Turner\u2019s syndrome","volume":"2","author":"Ferrier","year":"1965","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00282093","article-title":"De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy","volume":"74","author":"Chelly","year":"1986","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/humu.24191","article-title":"A single NGS-based assay covering the entire genomic sequence of the DMD gene facilitates diagnostic and newborn screening confirmatory testing","volume":"42","author":"Nallamilli","year":"2021","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","article-title":"CRISPR correction of Duchenne muscular dystrophy","volume":"70","author":"Min","year":"2019","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jpm9010016","article-title":"Mutation-based therapeutic strategies for Duchenne muscular dystrophy: from genetic diagnosis to therapy","volume":"9","author":"Nakamura","year":"2019","journal-title":"Journal of personalized medicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm9010001","article-title":"Restoring dystrophin expression in Duchenne muscular dystrophy: current status of therapeutic approaches","volume":"9","author":"Shimizu-Motohashi","year":"2019","journal-title":"Journal of personalized medicine"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015286","article-title":"Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin\/utrophin double knockout mice","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.130544_bb0100","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-018-1062-0","article-title":"A review of quality of life themes in Duchenne muscular dystrophy for patients and carers","volume":"16","author":"Uttley","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/dmcn.13934","article-title":"Duchenne muscular dystrophy and caregiver burden: a systematic review","volume":"60","author":"Landfeldt","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","article-title":"The burden of Duchenne muscular dystrophy: an international, cross-sectional study","volume":"83","author":"Landfeldt","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1182524","article-title":"Evolution and developmental functions of the dystrophin-associated protein complex: beyond the idea of a muscle-specific cell adhesion complex","volume":"11","author":"Mirouse","year":"2023","journal-title":"Frontiers in cell and developmental biology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/nat.2020.0856","article-title":"Approaches for systemic delivery of dystrophin antisense peptide nucleic acid in the mdx mouse model","volume":"31","author":"Brolin","year":"2021","journal-title":"Nucleic Acid Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0135","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.139.2.375","article-title":"Animal models for muscular dystrophy show different patterns of sarcolemmal disruption","volume":"139","author":"Straub","year":"1997","journal-title":"J. Cell Biol."},{"issue":"9307","key":"10.1016\/j.ijbiomac.2024.130544_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0150","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The Dystrophin Complex: structure, function and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0155","unstructured":"J.M. Ervasti, Structure and function of the dystrophin-glycoprotein complex, Madame curie bioscience database [Internet], Landes Bioscience2013."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0160","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1083\/jcb.135.3.661","article-title":"A new model for the interaction of dystrophin with F-actin","volume":"135","author":"Rybakova","year":"1996","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0165","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1083\/jcb.119.5.1183","article-title":"Direct visualization of the dystrophin network on skeletal muscle fiber membrane","volume":"119","author":"Straub","year":"1992","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","article-title":"The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein","volume":"53","author":"Koenig","year":"1988","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0175","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/S0021-9258(19)39599-7","article-title":"Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility","volume":"265","author":"Koenig","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/hmg\/ddh087","article-title":"ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to \u03b2-dystroglycan","volume":"13","author":"Ishikawa-Sakurai","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0185","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1083\/jcb.145.6.1325","article-title":"\u03b1-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability","volume":"145","author":"Montanaro","year":"1999","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.130544_bb0195","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1093\/hmg\/ddw210","article-title":"Dystrophin contains multiple independent membrane-binding domains","volume":"25","author":"Zhao","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"43","key":"10.1016\/j.ijbiomac.2024.130544_bb0200","doi-asserted-by":"crossref","first-page":"28419","DOI":"10.1074\/jbc.273.43.28419","article-title":"A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction","volume":"273","author":"Amann","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.200905048","article-title":"Dystrophin is a microtubule-associated protein","volume":"186","author":"Prins","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0210","article-title":"Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle","volume":"37","author":"D\u2019anna","year":"2020","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130544_bb0215","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1091\/mbc.e05-02-0112","article-title":"Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19","volume":"16","author":"Stone","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0220","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bbrc.2006.05.192","article-title":"Interactions of intermediate filament protein synemin with dystrophin and utrophin","volume":"346","author":"Bhosle","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0225","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2008.10.018","article-title":"An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan","volume":"135","author":"Ayalon","year":"2008","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0230","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.200604179","article-title":"Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with \u03b2-dystroglycan","volume":"176","author":"Rezniczek","year":"2007","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0235","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/77923","article-title":"Structure of a WW domain containing fragment of dystrophin in complex with \u03b2-dystroglycan","volume":"7","author":"Huang","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0240","doi-asserted-by":"crossref","unstructured":"B. Constantin, Dystrophin complex functions as a scaffold for signalling proteins, Biochim. Biophys. Acta (BBA)-Biomembranes 1838(2) (2014) 635\u2013642.","DOI":"10.1016\/j.bbamem.2013.08.023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10974-008-9165-6","article-title":"Biology of myospryn: what\u2019s known?","volume":"29","author":"Sarparanta","year":"2008","journal-title":"J. Muscle Res. Cell Motil."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0255","first-page":"209","article-title":"Utrophin upregulation in Duchenne muscular dystrophy","volume":"24","author":"Hirst","year":"2005","journal-title":"Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molmed.2006.01.002","article-title":"Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?","volume":"12","author":"Miura","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40259-023-00632-3","article-title":"Dystrophin-and utrophin-based therapeutic approaches for treatment of Duchenne muscular dystrophy: a comparative review","volume":"38","author":"Szwec","year":"2024","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0270","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2009.11.144","article-title":"The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b","volume":"391","author":"Yamashita","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0275","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1073\/pnas.1211431109","article-title":"\u03b12 and \u03b13 helices of dystrophin R16 and R17 frame a microdomain in the \u03b11 helix of dystrophin R17 for neuronal NOS binding","volume":"110","author":"Lai","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0280","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1074\/jbc.270.10.4975","article-title":"Identification of \u03b1-syntrophin binding to syntrophin triplet, dystrophin, and utrophin","volume":"270","author":"Yang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1078\/0171-9335-00415","article-title":"Syntrophin is an actin-binding protein the cellular localization of which is regulated through cytoskeletal reorganization in skeletal muscle cells","volume":"83","author":"Iwata","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.130544_bb0290","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.94.23.12413","article-title":"Dystrobrevin and dystrophin: an interaction through coiled-coil motifs","volume":"94","author":"Sadoulet-Puccio","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0295","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1074\/jbc.271.12.6605","article-title":"Ca2+-calmodulin binds to the carboxyl-terminal domain of dystrophin","volume":"271","author":"Anderson","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.130544_bb0300","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1074\/jbc.C700221200","article-title":"Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy","volume":"283","author":"Reynolds","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6212","key":"10.1016\/j.ijbiomac.2024.130544_bb0305","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0887-8994(95)00251-0","article-title":"Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy","volume":"14","author":"Boland","year":"1996","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-018-0177-7","article-title":"Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers","volume":"8","author":"Houang","year":"2018","journal-title":"Skelet. Muscle"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0960-8966(93)90018-F","article-title":"Duchenne muscular dystrophy\u2014Meryon\u2019s disease","volume":"3","author":"Emery","year":"1993","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation\u2013contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0335","series-title":"Duchenne Muscular Dystrophy: Methods and Protocols","first-page":"231","article-title":"Advanced methods to study the cross talk between fibro-adipogenic progenitors and muscle stem cells","author":"Tucciarone","year":"2018"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0340","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0345","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0350","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","article-title":"Fracture prevalence in Duchenne muscular dystrophy","volume":"44","author":"McDonald","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130544_bb0355","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1096\/fj.10-178913","article-title":"Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex","volume":"25","author":"Townsend","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0360","series-title":"Duchenne Muscular Dystrophy: Methods and Protocols","first-page":"19","article-title":"Clinical manifestations and overall management strategies for Duchenne muscular dystrophy","author":"Tsuda","year":"2018"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0365","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.2105118","article-title":"Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea","volume":"165","author":"Amin","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004347","article-title":"Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up","volume":"4","author":"Desguerre","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-11-20","article-title":"Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice","volume":"11","author":"Spurney","year":"2011","journal-title":"BMC Cardiovasc. Disord."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0380","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3345\/kjp.2014.57.5.232","article-title":"Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy","volume":"57","author":"Lee","year":"2014","journal-title":"Korean J. Pediatr."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.130544_bb0385","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.130544_bb0390","first-page":"979","article-title":"Mutation-based therapy for Duchenne muscular dystrophy: Antisense treatment arrives in the clinic","volume":"136","author":"McNally","year":"2017","journal-title":"Am Heart Assoc"},{"issue":"Supplement_2","key":"10.1016\/j.ijbiomac.2024.130544_bb0395","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1542\/peds.2018-0333I","article-title":"Cardiac management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Buddhe","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0400","first-page":"1125","article-title":"Respiratory support of individuals with Duchenne muscular dystrophy: toward a standard of care","volume":"16","author":"Benditt","year":"2005","journal-title":"Physical Medicine and Rehabilitation Clinics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0405","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1378\/chest.112.4.1024","article-title":"Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy","volume":"112","author":"Bach","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0415","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1073\/pnas.88.4.1276","article-title":"Dystrophin is transcribed in brain from a distant upstream promoter","volume":"88","author":"Boyce","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0420","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.24122","article-title":"Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction","volume":"75","author":"Paterson","year":"2014","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0425","first-page":"497","article-title":"Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients","volume":"43","author":"Cotton","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0430","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pediatrneurol.2005.08.029","article-title":"Are males with Duchenne muscular dystrophy at risk for reading disabilities?","volume":"34","author":"Hendriksen","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0435","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073807309775","article-title":"Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive\u2014compulsive disorder","volume":"23","author":"Hendriksen","year":"2008","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0440","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.43.4.795","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma","volume":"43","author":"Ohlendieck","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0445","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface","volume":"54","author":"Bonilla","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0450","article-title":"Assessing functional performance in the mdx mouse model","volume":"85","author":"Aartsma-Rus","year":"2014","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"6335","key":"10.1016\/j.ijbiomac.2024.130544_bb0455","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130544_bb0460","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.35.4.451","article-title":"Structural changes in the early stages of Duchenne muscular dystrophy","volume":"35","author":"Bradley","year":"1972","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0470","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/brain\/85.1.109","article-title":"Histopathological features of muscle in the preclinical stages of muscular dystrophy","volume":"85","author":"Pearson","year":"1962","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0475","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0092-8674(95)90471-9","article-title":"Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy","volume":"82","author":"Brenman","year":"1995","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.ijbiomac.2024.130544_bb0480","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.1073\/pnas.250379497","article-title":"Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy","volume":"97","author":"Sander","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-018-0182-x","article-title":"Dystrophin R16\/17-syntrophin PDZ fusion protein restores sarcolemmal nNOS\u03bc","volume":"8","author":"Patel","year":"2018","journal-title":"Skelet. Muscle"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0490","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/hum.2017.095","article-title":"Dual AAV gene therapy for Duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model","volume":"29","author":"Kodippili","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"6048","key":"10.1016\/j.ijbiomac.2024.130544_bb0495","first-page":"1440","volume":"333","author":"Prosser","year":"2011","journal-title":"X-ROS signaling: rapid mechano-chemo transduction in heart, Science"},{"issue":"236","key":"10.1016\/j.ijbiomac.2024.130544_bb0500","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002829","article-title":"Microtubules underlie dysfunction in duchenne muscular dystrophy","volume":"5","author":"Khairallah","year":"2012","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0505","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.2799","article-title":"Nitrosative stress elicited by nNOS\u03bc delocalization inhibits muscle force in dystrophin-null mice","volume":"223","author":"Li","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10974-012-9330-9","article-title":"Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy","volume":"34","author":"Kim","year":"2013","journal-title":"J. Muscle Res. Cell Motil."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0515","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds","year":"2020","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0520","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jemt.1172","article-title":"Role of nitric oxide in the pathogenesis of muscular dystrophies: a \u201ctwo hit\u201d hypothesis of the cause of muscle necrosis","volume":"55","author":"Rando","year":"2001","journal-title":"Microsc. Res. Tech."},{"issue":"6192","key":"10.1016\/j.ijbiomac.2024.130544_bb0525","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/335735a0","article-title":"Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice","volume":"335","author":"Turner","year":"1988","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0530","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm1736","article-title":"Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy","volume":"14","author":"Millay","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0535","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/cvr\/cvs425","article-title":"Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy","volume":"97","author":"Kyrychenko","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0540","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0545","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fj.201700182RRR","article-title":"Ryanodine channel complex stabilizer compound S48168\/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy","volume":"32","author":"Capogrosso","year":"2018","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0550","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41467-017-01146-7","article-title":"Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice","volume":"8","author":"Voit","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0555","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ymthe.2019.12.011","article-title":"Single SERCA2a therapy ameliorated dilated cardiomyopathy for 18 months in a mouse model of Duchenne muscular dystrophy","volume":"28","author":"Wasala","year":"2020","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0560","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0565","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/jcm8050649","article-title":"The \u201cusual suspects\u201d: genes for inflammation, fibrosis, regeneration, and muscle strength modify Duchenne muscular dystrophy","volume":"8","author":"Bello","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0570","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/cells9071659","article-title":"\u201cThe Social Network\u201d and muscular dystrophies: the lesson learnt about the niche environment as a target for therapeutic strategies","volume":"9","author":"Cappellari","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0575","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00018-008-7574-8","article-title":"Two-tiered hypotheses for Duchenne muscular dystrophy","volume":"65","author":"Grounds","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0580","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcp.21684","article-title":"Dystrophin glycoprotein complex-associated G\u03b2\u03b3 subunits activate phosphatidylinositol-3-kinase\/Akt signaling in skeletal muscle in a laminin-dependent manner","volume":"219","author":"Xiong","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0585","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fnagi.2014.00188","article-title":"Skeletal muscle homeostasis in duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy","volume":"6","author":"De Palma","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0590","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.pmrj.2009.04.010","article-title":"Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention","volume":"1","author":"Evans","year":"2009","journal-title":"PM&R"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0595","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/j.2040-4603.2018.tb00051.x","article-title":"Immunobiology of inherited muscular dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr. Physiol."},{"issue":"299","key":"10.1016\/j.ijbiomac.2024.130544_bb0600","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.RES.72.2.349","article-title":"Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle","volume":"72","author":"Klietsch","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0610","series-title":"Proteomic Analysis Reveals New Cardiac-specific Dystrophin-associated Proteins","author":"Johnson","year":"2012"},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.130544_bb0615","doi-asserted-by":"crossref","first-page":"e1597","DOI":"10.1212\/WNL.0000000000008363","article-title":"TREAT-NMD, relationships between DMD mutations and neurodevelopment in dystrophinopathy","volume":"93","author":"Thangarajh","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0620","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.24222","article-title":"Reduced cerebral gray matter and altered white matter in boys with D uchenne muscular dystrophy","volume":"76","author":"Doorenweerd","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-009-8089-5","article-title":"The roles of the dystrophin-associated glycoprotein complex at the synapse","volume":"41","author":"Pilgram","year":"2010","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133214","article-title":"Early neurodevelopmental findings predict school age cognitive abilities in Duchenne muscular dystrophy: a longitudinal study","volume":"10","author":"Chieffo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2014.10.004","article-title":"Acetylcholine, GABA and neuronal networks: a working hypothesis for compensations in the dystrophic brain","volume":"110","author":"Cohen","year":"2015","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0640","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.nmd.2020.05.001","article-title":"Combining genetics, neuropsychology and neuroimaging to improve understanding of brain involvement in Duchenne muscular dystrophy-a narrative review","volume":"30","author":"Doorenweerd","year":"2020","journal-title":"Neuromuscul. Disord."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0645","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0650","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"8\u20139","key":"10.1016\/j.ijbiomac.2024.130544_bb0655","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nmd.2004.05.001","article-title":"Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols","volume":"14","author":"Biggar","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"10119","key":"10.1016\/j.ijbiomac.2024.130544_bb0660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0665","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0670","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"5","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0675","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/mus.26441","article-title":"Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy","volume":"59","author":"Connolly","year":"2019","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0680","first-page":"9","article-title":"Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy","volume":"31","author":"Angelini","year":"2012","journal-title":"Acta Myologica"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0685","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0690","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0695","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0700","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2018.012","article-title":"Micro-dystrophin gene therapy goes systemic in Duchenne muscular dystrophy patients","volume":"29","author":"Duan","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"R1","key":"10.1016\/j.ijbiomac.2024.130544_bb0705","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0710","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1006\/geno.1993.1225","article-title":"Exon structure of the human dystrophin gene","volume":"16","author":"Roberts","year":"1993","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0715","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0720","first-page":"243","volume":"1772","author":"Odom","year":"2007","journal-title":"Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0725","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of novel micro-dystrophins with enhanced functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0730","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1566523215666150710123830","article-title":"Adeno-associated virus (AAV) mediated dystrophin gene transfer studies and exon skipping strategies for Duchenne muscular dystrophy (DMD)","volume":"15","author":"Kawecka","year":"2015","journal-title":"Curr. Gene Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0735","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/hum.2013.210","article-title":"Full-length dystrophin reconstitution with adeno-associated viral vectors","volume":"25","author":"Lostal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0740","doi-asserted-by":"crossref","unstructured":"J. Morgan, F. Muntoni, Changes in myonuclear number during postnatal growth\u2013implications for AAV gene therapy for muscular dystrophy, Journal of Neuromuscular Diseases 8(s2) (2021) S317-S324.","DOI":"10.3233\/JND-210683"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0745","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fmicb.2011.00194","article-title":"Innate immune responses to AAV vectors","volume":"2","author":"Rogers","year":"2011","journal-title":"Front. Microbiol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.130544_bb0750","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","article-title":"Quantitative analysis of the packaging capacity of recombinant adeno-associated virus","volume":"7","author":"Dong","year":"1996","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0755","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130544_bb0760","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0765","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum. Mutat."},{"issue":"6524","key":"10.1016\/j.ijbiomac.2024.130544_bb0770","first-page":"29","volume":"371","author":"Ferlini","year":"2021","journal-title":"RNA-targeted drugs for neuromuscular diseases, Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130544_bb0775","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/genes11080837","article-title":"Therapeutic strategies for Duchenne muscular dystrophy: an update","volume":"11","author":"Sun","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0780","first-page":"29","volume":"32","author":"Servais","year":"2022","journal-title":"Long-term safety and efficacy data of golodirsen in ambulatory patients with Duchenne muscular dystrophy amenable to exon 53 skipping: a first-in-human, multicenter, two-part, open-label, phase 1\/2 trial, Nucleic Acid Therapeutics"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.130544_bb0785","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0790","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/acn3.51235","article-title":"Viltolarsen in Japanese Duchenne muscular dystrophy patients: a phase 1\/2 study","volume":"7","author":"Komaki","year":"2020","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0795","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15252\/emmm.201607199","article-title":"Delivery is key: lessons learnt from developing splice-switching antisense therapies","volume":"9","author":"Godfrey","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0800","series-title":"Exon Skipping and Inclusion Therapies: Methods and Protocols","first-page":"381","article-title":"Use of tricyclo-DNA antisense oligonucleotides for exon skipping","author":"Relizani","year":"2018"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0805","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130544_bb0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081302","article-title":"Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy","volume":"8","author":"Finkel","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0815","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"issue":"10101","key":"10.1016\/j.ijbiomac.2024.130544_bb0820","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0825","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/cer-2019-0171","article-title":"Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study","volume":"9","author":"Mercuri","year":"2020","journal-title":"Journal of Comparative Effectiveness Research"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.130544_bb0830","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14656566.2020.1732350","article-title":"New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics","volume":"21","author":"Grages","year":"2020","journal-title":"Expert. Opin. Pharmacother."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.130544_bb0835","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","article-title":"Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function","volume":"93","author":"Hoffman","year":"2019","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.130544_bb0840","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.3390\/ijms21134596","article-title":"Anti-inflammatory and general glucocorticoid physiology in skeletal muscles affected by Duchenne muscular dystrophy: exploration of steroid-sparing agents","volume":"21","author":"Herbelet","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0845","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jpm8040038","article-title":"Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy","volume":"8","author":"Lim","year":"2018","journal-title":"Journal of personalized medicine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0850","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0855","doi-asserted-by":"crossref","unstructured":"C.E. Nelson, C.H. Hakim, D.G. Ousterout, P.I. Thakore, E.A. Moreb, R.M.C. Rivera, S. Madhavan, X. Pan, F.A. Ran, W.X. Yan, In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy, Science 351(6271) (2016) 403\u2013407.","DOI":"10.1126\/science.aad5143"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0860","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0865","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.130544_bb0870","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130544_bb0875","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0880","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0885","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41434-019-0119-y","article-title":"Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components","volume":"27","author":"Maggio","year":"2020","journal-title":"Gene Ther."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.130544_bb0890","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1073\/pnas.1820523116","article-title":"Unified energetics analysis unravels SpCas9 cleavage activity for optimal gRNA design","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0895","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0900","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.130544_bb0905","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.130544_bb0910","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124297","article-title":"AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice","volume":"3","author":"Hakim","year":"2018","journal-title":"JCI Insight"},{"issue":"6481","key":"10.1016\/j.ijbiomac.2024.130544_bb0915","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"science"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130544_bb0920","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ymthe.2019.06.012","article-title":"AAV9 edits muscle stem cells in normal and dystrophic adult mice","volume":"27","author":"Nance","year":"2019","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130544_bb0925","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17460441.2020.1718100","article-title":"Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine","volume":"15","author":"Wasala","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"R2","key":"10.1016\/j.ijbiomac.2024.130544_bb0930","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","article-title":"Exon-skipping advances for Duchenne muscular dystrophy","volume":"27","author":"Echevarr\u00eda","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130544_bb0935","first-page":"251","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Development of exon skipping therapies for Duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues, Nucleic Acid Therapeutics"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0940","series-title":"Sarepta Therapeutics Announces Positive Expression Results From the Casimersen (SRP-4045) Arm of the ESSENCE Study","author":"Therapeutics","year":"2019"},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0945","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.130544_bb0950","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","article-title":"Pharmacological advances for treatment in Duchenne muscular dystrophy","volume":"34","author":"Guiraud","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130544_bb0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246507","article-title":"Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice","volume":"16","author":"Ziemba","year":"2021","journal-title":"PLoS One"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024013473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024013473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:16:40Z","timestamp":1758885400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024013473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":191,"alternative-id":["S0141813024013473"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130544","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130544"}}